TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Vireo Growth ( (TSE:VREO) ) just unveiled an announcement.
Vireo Growth Inc. and Verano Holdings Corp. announced a comprehensive settlement resolving all outstanding litigation matters between them, with Vireo receiving approximately $10 million in value. This resolution allows both companies to focus on their strategic priorities without the distraction of ongoing litigation, marking a significant step forward in their commitment to delivering long-term value to shareholders and quality products to customers.
The most recent analyst rating on (TSE:VREO) stock is a Hold with a C$0.55 price target. To see the full list of analyst forecasts on Vireo Growth stock, see the TSE:VREO Stock Forecast page.
More about Vireo Growth
Vireo Growth Inc. is a pioneering medical cannabis company founded in 2014, focusing on building a disciplined and strategically aligned platform in the cannabis industry. The company emphasizes local market focus while leveraging a national portfolio, with a commitment to its customers, employees, shareholders, and communities. Verano Holdings Corp. is a leading U.S. cannabis company known for its historical revenue, geographic scope, and brand performance. It operates as a vertically integrated, multi-state operator with a mission to advance cannabis use, offering a range of high-quality cannabis products under various consumer brands across 13 U.S. states.
Average Trading Volume: 76,459
Technical Sentiment Signal: Buy
Current Market Cap: C$826.3M
See more data about VREO stock on TipRanks’ Stock Analysis page.